RECHEM
Welcome to our website!|Hot Line: 86-21-51623867|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-51623867 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ1: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10001 | R788; Fostamatinib | Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor |
| R10002 | R406 Free base | R406 (free base) is a potent Syk inhibitor with IC50 of 41 nM in a cell-free ass |
| R10097 | GNF-2 | GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no a |
| R10124 | Ibrutinib;PCI-32765 | Ibrutinib (PCI-32765) is a potent and highly selective Brutons tyrosine kinase ( |
| R10181 | AP24534; Ponatinib | Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VE |
| R10204 | PF562271 | PF-562271 is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of |
| R10334 | SU6656 | SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 1 |
| R10367 | NVPTAE226 | TAE226 (NVP-TAE226) is a potent FAK inhibitor with IC50 of 5.5 nM and modestly p |
| R10496 | Dasatinib;BMS-354825;BMS354825 | Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src |
| R10503 | Nilotinib; AMN-107 | Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine m |
| R10677 | WH-4-023 | WH-4-023 is a potent and orally active Lck/Src inhibitor with IC50 of 2 nM and 6 |
| R10831 | Dasatinib monohydrate | Dasatinib Monohydrate is a novel, potent and multi-targeted inhibitor that targe |
| R10873 | CNX-774 | CNX-774 is an irreversible, orally active, and highly selective BTK inhibitor wi |
| R10875 | Entospletinib (GS-9973) | Entospletinib (GS-9973) is an orally bioavailable, selective Syk inhibitor with |
| R10917 | Radotinib; IY-5511 | Radotinib(IY-5511) is a novel and selective BCR-ABL1 tyrosine kinase inhibitor w |
| R10967 | PF-431396 | PF-431396 is a dual PYK2/FAK inhibitor with IC50 of 11 nM and 2 nM, respectively |
| R10997 | GNF-7 | GNF-7 is a potent type-II kinase Bcr-Abl inhibitor with IC50 of <5 nM, 61 nM, |
| R11448 | Fostamatinib Disodium (Synonyms: R788(Disodium)) | R788 (Fostamatinib) disodium, a prodrug of the active metabolite R406, is a Syk |
| R11633 | GZD824 (Synonyms: HQP1351) | GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(W |
| R11585 | BAY 61-3606 dihydrochloride | BAY 61-3606 dihydrochloride is an orally available, ATP-competitive, reversible |
| R912032 | jnd3229 | JND3229 is a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy (IC50 |
| R2032482 | Pacritinib(SB1518) | Pacritinib is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V61 |
Page 1 / Total 1 FirstPrevNextLastGoto
